Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Retained Earnings (2016 - 2025)

Lipocine (LPCN) has disclosed Retained Earnings for 13 consecutive years, with $4627.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Retained Earnings rose 100.0% year-over-year to $4627.0, compared with a TTM value of $4627.0 through Sep 2025, up 100.0%, and an annual FY2024 reading of $9138.0, up 100.0% over the prior year.
  • Retained Earnings was $4627.0 for Q3 2025 at Lipocine, up from -$1243.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $9138.0 in Q4 2024 and bottomed at -$201.6 million in Q3 2024.
  • Average Retained Earnings over 5 years is -$60.5 million, with a median of -$20321.0 recorded in 2022.
  • The sharpest move saw Retained Earnings tumbled 96121386.56% in 2022, then soared 152.07% in 2025.
  • Year by year, Retained Earnings stood at -$18016.0 in 2021, then fell by 12.79% to -$20321.0 in 2022, then tumbled by 983007.2% to -$199.8 million in 2023, then skyrocketed by 100.0% to $9138.0 in 2024, then crashed by 49.37% to $4627.0 in 2025.
  • Business Quant data shows Retained Earnings for LPCN at $4627.0 in Q3 2025, -$1243.0 in Q2 2025, and $5521.0 in Q1 2025.